Parkin deletion affects PINK1/Parkin-mediated mitochondrial autophagy to exacerbate neuroinflammation and accelerate progression of Parkinson's disease in mice

doi:10.12122/j.issn.1673-4254.2024.12.11

Abstract

Abstract:

Objective To investigate the role of mitochondrial autophagy disorder caused by deletion of E3 ubiquitin ligase Parkin in neuroinflammation in a mouse model of MPTP-induced Parkinson's disease (PD). Methods Wild-type (WT) male C57BL/6 mice and Parkin^-/-mice were given intraperitoneal injections with MPTP or PBS for 5 consecutive days, and the changes in motor behaviors of the mice were observed using open field test. The effects of Parkin deletion on PD development and neuroinflammation were evaluated using immunofluorescence and Western blotting. The changes of the PINK 1/Parkin signaling pathway in the midbrain substantia nigra of the mice were examined to explore the molecular mechanism of Parkin-mediated regulation of mitochondrial autophagy and its effect on neuroinflammation in PD mice. Results Compared with their WT counterparts, the Parkin^-/- mice with MPTP injections exhibited significant impairment of motor function with decreased TH⁺ neurons, increased α-synuclein (α-syn) accumulation, and increased numbers of GFAP⁺ and I-ba1⁺ cells in the midbrain substantia nigra. Parkin deletion obviously affected PINK1/Parkin-mediated mitochondrial autophagy to result in significantly increased mtDNA and upregulated expressions of STING and NLRP3 inflammatosomes in the midbrain substantia nigra of MPTP-treated transgenic mice. Conclusion Parkin deletion causes mitochondrial autophagy disorder to accelerate PD progression and exacerbates neuroinflammation in mice by affecting the PINK1/Parkin signaling pathway, suggesting the important role of Parkin in early pathogenesis of PD.

Key words: Parkinson's disease, Parkin, neuroinflammation, mitochondrial autophagy

Chengcheng JIANG, Yangyang LI, Kexin DUAN, Tingting ZHAN, Zilong CHEN, Yongxue WANG, Rui ZHAO, Caiyun MA, Yu GUO, Changqing LIU. Parkin deletion affects PINK1/Parkin-mediated mitochondrial autophagy to exacerbate neuroinflammation and accelerate progression of Parkinson's disease in mice[J]. Journal of Southern Medical University, 2024, 44(12): 2359-2366.

Figures/Tables 4

Fig.1 Behavioral test of wild-type (WT) and Parkin-/- mice after MPTP injection. A: Flow chart of MPTP-PD modeling in the mice. B: Heat map of movement of the mice in open field tests. C: Motion trajectory graph of the mice. D, E: Statistics of total movement distance and the distance in the central area of the mice in open field test. **P<0.01, ***P<0.001.

Fig.2 MPTP-induced Parkinson's disease in WT and Parkin-/- mice. A: Immunofluorescence staining of dopaminergic neuron markers TH (red) and DAPI (blue). B: Protein expression level of TH in the midbrain substantia nigra. C: Analysis of TH protein expression. D: Immunofluorescence staining of α-syn (red) and DAPI (blue) in the mouse midbrain. **P<0.01, ***P<0.001.

Fig.3 Parkin deletion increased neuroinflammation induced by MPTP in mice. A: Immunofluorescence staining of astrocyte markers GFAP (red) and DAPI (blue). B: Co-staining of microglial marker I-ba1 (red) and NLRP3 (green) inflammasomes. C: Analysis of GFAP+ cell count (%). D: Analysis of I-ba1+ cell count (%).**P<0.01, ***P<0.001, ****P<0.0001.

Fig.4 Molecular mechanism of Parkin-mediated regulation of mitochondrial autophagy in midbrain substantia nigra. A: Immunofluorescence assay showing abnormal mitochondrial autophagy (white arrows) in Parkin-/- mice with MPTP injection. B: Western blotting for detecting protein changes in Parkin-mediated regulation of mitochondrial autophagy and neuroinflammation. C: Scanning densitometry for semi-quantitative analysis of the protein expression levels. *P<0.05, **P<0.01 vs WT-MPTP.

References 32

1	Tolosa E, Garrido A, Scholz SW, et al. Challenges in the diagnosis of Parkinson's disease[J]. Lancet Neurol, 2021, 20(5): 385-97.
2	Jankovic J, Tan EK. Parkinson's disease: etiopathogenesis and treatment[J]. J Neurol Neurosurg Psychiatry, 2020, 91(8): 795-808.
3	Kwon EH, Steininger J, Scherbaum R, et al. Large-fiber neuropathy in Parkinson's disease: a narrative review[J]. Neurol Res Pract, 2024, 6(1): 51.
4	Araújo B, Caridade-Silva R, Soares-Guedes C, et al. Neuro-inflammation and Parkinson's disease-from neurodegeneration to therapeutic opportunities[J]. Cells, 2022, 11(18): 2908.
5	Pajares M, Rojo AI, Manda G, et al. Inflammation in Parkinson's disease: mechanisms and therapeutic implications[J]. Cells, 2020, 9(7): 1687.
6	Moradi Vastegani S, Nasrolahi A, Ghaderi S, et al. Mitochondrial dysfunction and Parkinson's disease: pathogenesis and therapeutic strategies[J]. Neurochem Res, 2023, 48(8): 2285-308.
7	Ryan BJ, Hoek S, Fon EA, et al. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease[J]. Trends Biochem Sci, 2015, 40(4): 200-10.
8	Chen CY, Yang C, Wang J, et al. Melatonin ameliorates cognitive deficits through improving mitophagy in a mouse model of Alzheimer's disease[J]. J Pineal Res, 2021, 71(4): e12774.
9	Zuo L, Motherwell MS. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease[J]. Gene, 2013, 532(1): 18-23.
10	O’Hanlon ME, Tweedy C, Scialo F, et al. Mitochondrial electron transport chain defects modify Parkinson's disease phenotypes in a Drosophila model[J]. Neurobiol Dis, 2022, 171: 105803.
11	Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease[J]. Neuron, 2015, 85(2): 257-73.
12	Kamienieva I, Duszyński J, Szczepanowska J. Multitasking guardian of mitochondrial quality: Parkin function and Parkinson's disease[J]. Transl Neurodegener, 2021, 10(1): 5.
13	Liu J, Liu WJ, Lu YQ, et al. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models[J]. Autophagy, 2018, 14(5): 845-61.
14	Barazzuol L, Giamogante F, Brini M, et al. PINK1/parkin mediated mitophagy, Ca²⁺ signalling, and ER-mitochondria contacts in Parkinson's disease[J]. Int J Mol Sci, 2020, 21(5): 1772.
15	Eiyama A, Okamoto K. PINK1/Parkin-mediated mitophagy in mammalian cells[J]. Curr Opin Cell Biol, 2015, 33: 95-101.
16	Wasner K, Smajic S, Ghelfi J, et al. Parkin deficiency impairs mitochondrial DNA dynamics and propagates inflammation[J]. Mov Disord, 2022, 37(7): 1405-15.
17	Geisler S, Holmström KM, Skujat D, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1[J]. Nat Cell Biol, 2010, 12(2): 119-31.
18	Ren ZL, Wang CD, Wang T, et al. Ganoderma lucidum extract ameliorates MPTP-induced Parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis[J]. Acta Pharmacol Sin, 2019, 40(4): 441-50.
19	Chia SJ, Tan EK, Chao YX. Historical perspective: models of Parkinson's disease[J]. Int J Mol Sci, 2020, 21(7): E2464.
20	Xu JJ, Li YY, Zhu H, et al. Therapeutic function of a novel rat induced pluripotent stem cell line in a 6-OHDA-induced rat model of Parkinson's disease[J]. Int J Mol Med, 2022, 50(6): 140.
21	Noda S, Sato S, Fukuda T, et al. Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice[J]. Neurobiol Dis, 2020, 136: 104717.
22	Li J, Yang DM, Li ZP, et al. PINK1/Parkin-mediated mitophagy in neurodegenerative diseases[J]. Ageing Res Rev, 2023, 84: 101817.
23	Zhang XW, Feng N, Liu YC, et al. Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy[J]. Sci Adv, 2022, 8(32): eabo0789.
24	Jurcau A, Andronie-Cioara FL, Nistor-Cseppento DC, et al. The involvement of neuroinflammation in the onset and progression of Parkinson's disease[J]. Int J Mol Sci, 2023, 24(19): 14582.
25	Quinn PMJ, Moreira PI, Ambrósio AF, et al. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation[J]. Acta Neuropathol Commun, 2020, 8(1): 189.
26	Iorio R, Celenza G, Petricca S. Multi-target effects of β‑caryo-phyllene and carnosic acid at the crossroads of mitochondrial dysfunction and neurodegeneration: from oxidative stress to microglia-mediated neuroinflammation[J]. Antioxidants, 2022, 11(6): 1199.
27	Sun K, Jing XZ, Guo JC, et al. Mitophagy in degenerative joint diseases[J]. Autophagy, 2021, 17(9): 2082-92.
28	Panicker N, Kam TI, Wang H, et al. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease[J]. Neuron, 2022, 110(15): 2422-37.e9.
29	Lee E, Hwang I, Park S, et al. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration[J]. Cell Death Differ, 2019, 26(2): 213-28.
30	Zengeler KE, Lukens JR. Taking the parkin brakes off of neuronal NLRP3 drives inflammasome activation and neurodegeneration in Parkinson's disease[J]. Neuron, 2022, 110(15): 2356-8.
31	Sliter DA, Martinez J, Hao L, et al. Parkin and PINK1 mitigate STING-induced inflammation[J]. Nature, 2018, 561(7722): 258-62.
32	Eldeeb MA, Thomas RA, Ragheb MA, et al. Mitochondrial quality control in health and in Parkinson's disease[J]. Physiol Rev, 2022, 102(4): 1721-55.

[1]	Linyu XIAO, Ting DUAN, Yongsheng XIA, Yue CHEN, Yang SUN, Yibo XU, Lei XU, Xingzhou YAN, Jianguo HU. Linarin inhibits microglia activation-mediated neuroinflammation and neuronal apoptosis in mouse spinal cord injury by inhibiting the TLR4/NF-κB pathway [J]. Journal of Southern Medical University, 2024, 44(8): 1589-1598.
[2]	Feixia WANG, Zheng ZHANG, Yan SUN, Liujing YANG, Tongtong GUO, Yeting PAN, Songtao DING, Lin JIANG, Handeng LIU. Bmal1 mediates the neuroprotective effect of sodium butyrate in a mouse model of Parkinson's disease [J]. Journal of Southern Medical University, 2024, 44(5): 876-884.
[3]	GUI Jianjun, SUN Xiaodong, WEN Shu, LIU Xin, QIN Bingqing, SANG Ming. Resveratrol protects dopaminergic neurons in a mouse model of Parkinson's disease by regulating the gut-brain axis via inhibiting the TLR4 signaling pathway [J]. Journal of Southern Medical University, 2024, 44(2): 270-279.
[4]	Zijing REN, Peiyang ZHOU, Jing TIAN. Plasma long noncoding RNA expression profiles in patients with Parkinson's disease and the role of lnc-CTSD-5:1 in a PD cell model: a ceRNA microarray-based study [J]. Journal of Southern Medical University, 2024, 44(11): 2146-2155.
[5]	ZHANG Meng, ZHANG Yuanyuan, NIU Mengzhu, ZHU Yue, TONG Shiyi, KOU Xianjuan. Dihydromyricetin alleviates pyroptosis and necroptosis in mice with MPTP-induced chronic Parkinson's disease by inducing autophagy [J]. Journal of Southern Medical University, 2023, 43(8): 1268-1278.
[6]	XU Jiajia, LI Yangyang, ZHONG Guangshang, FANG Zhuling, LIU Chunbo, MA Caiyun, WANG Chunjing, GUO Yu, LIU Changqing. Directed differentiation of human induced pluripotent stem cells into midbrain dopaminergic neuron progenitors in vitro [J]. Journal of Southern Medical University, 2023, 43(2): 175-182.
[7]	ZHANG Jiafa, YANG Canhong, ZHANG Shufen, CAO Tingting, PENG Rui, GUO Weihong, YAN Yuping, XIE Shuting, PENG Xiaojia, LÜ Tianming, HUANG Tianrong. Sulforaphane reverses Aβ fiber-mediated M1 type microglia polarization and neuroinflammation-mediated necroptosis of neural stem cells by downregulating the MAPK/NF-κB signaling pathways [J]. Journal of Southern Medical University, 2023, 43(12): 2132-2138.
[8]	HUANG Chao, WANG Hongting, WANG Cunqin. 27-P-CAUA induces apoptosis and mitochondrial autophagy in breast cancer cells by inhibiting HER2/PI3K/AKT signaling pathway [J]. Journal of Southern Medical University, 2022, 42(1): 63-70.
[9]	. Macrophage migration inhibitory factor meditates MPP+/MPTP-induced NLRP3 inflammasome activation in microglia cells [J]. Journal of Southern Medical University, 2021, 41(7): 972-979.
[10]	. Directed differentiation of porcine induced pluripotent stem cells into forebrain GABAergic neuron progenitors [J]. Journal of Southern Medical University, 2021, 41(6): 820-827.
[11]	MU Feifei, CHEN Xi, DU Xixun, JIAO Qian, BI Mingxia, JIANG Hong. Regulatory mechanism of interferon regulatory factor 1 by α-synuclein in Parkinson's disease models [J]. Journal of Southern Medical University, 2021, 41(11): 1641-1648.
[12]	. Rosmarinic acid inhibits high glucose-induced cardiomyocyte hypertrophy by activating Parkin-mediated mitophagy [J]. Journal of Southern Medical University, 2020, 40(11): 1628-1633.
[13]	. Application of intracranial lead reconstruction in deep brain stimulation therapy in patients with Parkinson’s disease [J]. Journal of Southern Medical University, 2019, 39(12): 1461-1468.
[14]	. Quantitative magnetic resonance imaging of brain iron deposition: comparison between quantitative susceptibility mapping and transverse relaxation rate (R2*) mapping [J]. Journal of Southern Medical University, 2018, 38(03): 305-.
[15]	. Voxel-based analysis of cerebral blood flow changes in Parkinson disease using arterial spin labeling technique [J]. Journal of Southern Medical University, 2018, 38(01): 117-.